Immature forms of the peptide hormone gastrin have been implicated in the development of colorectal cancer (CRC). The biological activity of glycine-extended gastrin (Ggly) is dependent on the binding of Fe ions in vitro and in vivo. The aim of the present study was to determine the effect of blocking Fe ion binding to Ggly, using Bi, In or Ru ions, on the development of intestinal tumors in APC mice. APC mice were treated orally with Bi, In or Ru ions for up to 60 days, serum trace metals were analyzed by inductively coupled plasma mass spectrometry, and the incidence and size of intestinal tumors were assessed. Bi treatment significantly decreased the number of tumors larger than 3 mm in male mice. In or Ru treatment significantly increased the tumor burden in all animals and In increased the number of tumors larger than 3 mm or 5 mm in male mice alone. The fact that binding of In or Ru ions to Ggly was orders of magnitude stronger than the binding of Bi ions implies that the inhibitory effect of Bi ions is not a consequence of a reduction in Ggly activity. However, further testing of higher doses of Bi ions for longer periods as an oral treatment for intestinal tumors is warranted.